Atlas Trials

Identification of Predictive Epigenetic Biomarkers of Lung Disease Severity in Cystic Fibrosis

Clinical trial NCT02976714 · COMPLETED

Trial details

NCT number
NCT02976714
Sponsor
University Hospital, Montpellier
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2016-12-12
Primary completion
2021-07-13
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.